Percutaneous Coronary Intervention (PCI) With Drug-Eluting Stents (DES) Versus Coronary Artery Bypass Graft (CABG) for Patients With Significant Left Main Stenosis
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Recent technical advances in percutaneous coronary interventions have made it possible to approach patients with coronary lesions formerly considered to be classical candidates for bypass surgery, e.g. patients with left main coronary stenosis. However, it is still unclear whether the good long-term results achieved with the surgical therapy can be reproduced by an interventional strategy using drug-eluting stents (DES).
The aim of the current trial is, therefore, to compare the clinical and angiographic results of PCI and CABG in patients with left main coronary stenosis.
| Condition | Intervention | Phase |
|---|---|---|
|
Coronary Stenosis Coronary Artery Disease |
Procedure: Percutaneous coronary intervention (left main) |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | PCI With DES Versus CABG for Patients With Significant Left Main Stenosis |
- Major adverse coronary events (cardiac death, myocardial infarction, need for repeat revascularisation)
- Functional status (CCS-class)
| Estimated Enrollment: | 200 |
| Study Start Date: | August 2003 |
Recent technical advances in percutaneous coronary interventions have made it possible to approach patients with coronary lesions formerly considered to be classical candidates for bypass surgery, e.g. patients with left main coronary stenosis. However, it is still unclear whether the good long-term results achieved with the surgical therapy can be reproduced by an interventional strategy using drug-eluting stents (DES).
The aim of the current trial is, therefore, to compare the clinical and angiographic results of PCI and CABG in patients with left main coronary stenosis.
The study was planned as a "non-inferiority" trial based on the hypothesis that PCI may be able to reach similar long-term results as compared to CABG.
Eligibility| Ages Eligible for Study: | 18 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Significant left main coronary stenosis >= 50%
Exclusion Criteria:
- Acute myocardial infarction (STEMI < 48h)
Contacts and Locations| Contact: Enno Boudriot, MD | +49-341-865 ext 1428 | boue@medizin.uni-leipzig.de |
| Contact: Gerhard Schuler, MD | +49-341-865 ext 1428 | schug@medizin.uni-leipzig.de |
| Germany | |
| University of Leipzig, Heart Center | Recruiting |
| Leipzig, Saxony, Germany, 04289 | |
| Contact: Enno Boudriot, MD +49-341-865 ext 1428 boue@medizin.uni-leipzig.de | |
| Contact: Gerhard Schuler, MD +49-341-865 ext 1428 schug@medizin.uni-leipzig.de | |
| Sub-Investigator: Enno Boudriot, MD | |
| Study Director: | Gerhard Schuler, MD | University of Leipzig |
| Study Director: | Friedrich Mohr, MD | University of Leipzig |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00176397 History of Changes |
| Other Study ID Numbers: | 118/2003 |
| Study First Received: | September 13, 2005 |
| Last Updated: | September 6, 2007 |
| Health Authority: | Germany: Federal Institute for Drugs and Medical Devices |
Keywords provided by University of Leipzig:
|
left main coronary artery coronary artery disease |
Additional relevant MeSH terms:
|
Constriction, Pathologic Coronary Artery Disease Myocardial Ischemia Coronary Disease Coronary Stenosis Pathological Conditions, Anatomical |
Heart Diseases Cardiovascular Diseases Arteriosclerosis Arterial Occlusive Diseases Vascular Diseases |
ClinicalTrials.gov processed this record on June 18, 2013